AMRI stands for Albany Molecular Research Inc. It is a leading global contract research and manufacturing organization (CRMO) focused on drug discovery, development, and manufacturing services. AMRI offers a wide range of services, including medicinal chemistry, biology, in vitro and in vivo pharmacology, and drug metabolism and pharmacokinetics, to support various stages of the drug development process.
In terms of drug discovery, AMRI provides expertise in hit identification, lead optimization, and computational chemistry, using advanced technologies and methodologies to identify and design novel drug candidates. Their drug development services encompass formulation development, analytical and solid-state sciences, as well as preclinical and clinical trial materials manufacturing. Additionally, AMRI offers integrated services for pharmaceutical manufacturing, covering small-scale API production, large-scale cGMP manufacturing of drug products, and regulatory filing support.
With a strong focus on collaboration, AMRI partners with biotech and pharmaceutical companies, academic institutions, and government agencies to further scientific advancements and accelerate the development of innovative therapies. The company's commitment to quality, compliance, and customer satisfaction is reflected in their state-of-the-art facilities, robust regulatory expertise, and adherence to industry standards.
AMRI's contributions to the pharmaceutical industry have made it a trusted and reliable partner in advancing healthcare by translating scientific discoveries into safe and effective medicines. Through their comprehensive suite of solutions, AMRI plays a vital role in bringing new therapies to market, ultimately improving patient outcomes and transforming the landscape of modern medicine.
